TOP TIERMARKET NEWSWIRE
News & sentiment

ENTRADA THERAPEUTICS (TRDA) — News & AI sentiment

ENTRADA THERAPEUTICS (TRDA) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 51.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 12 sales totalling $10.3M — net selling of $10.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
4
avg sentiment 51.3/100
Insider net (90d)
$10.3M
0 buys · 12 sells
Congress (90d)
0
0 buys · 0 sells

TRDA news in the last 24 hours, 7 days, 30 days and 90 days

How much TRDA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTRDA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days451.3/100TRDA headlines →
Last 90 days748.4/100TRDA headlines →

Latest stories on TRDA

Sep 10
Sep 10
Sep 2
Sep 2
Entrada Therapeutics reports Q2 results
Seeking Alpha34 · bearishearnings
Aug 5
Aug 5
Aug 5
Jun 10
Jun 10
Jun 8
Jun 2
Jun 1
Jun 1
May 19
Open TRDA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →